← Back to Search

Acupuncture for Breast Cancer

N/A
Recruiting
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
With self-reported pain, fatigue, sleep disturbance in the last three months and their 'worst' severity rating ≥ 3 (0-10 numeric rating scale) for at least two of the three symptoms
Who have completed their primary cancer treatment (e.g., surgery, radiotherapy, chemotherapy) at least 3 months prior and within 5 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after 10th acupuncture treatment, at 6 weeks post-baseline (study completion)
Awards & highlights

Study Summary

This trial will study whether acupuncture is a feasible and acceptable treatment for breast cancer survivors, and will explore changes in biomarkers after the acupuncture intervention.

Who is the study for?
This trial is for English-speaking women who finished primary breast cancer treatment (stages 0-III) at least 3 months ago but within the last 5 years, are on adjuvant endocrine therapy, and suffer from pain, fatigue, or sleep issues with a severity of ≥3. Excluded are those with recent psychiatric hospitalization, bleeding disorders, pregnancy or inability to complete study procedures.Check my eligibility
What is being tested?
The study tests if acupuncture can alleviate psychoneurological symptoms like pain, fatigue, and sleep disturbances in breast cancer survivors. Participants will receive acupuncture treatments twice weekly over five weeks while researchers track changes in biomarkers.See study design
What are the potential side effects?
Acupuncture may cause minor side effects such as slight bleeding or bruising at needle sites, dizziness or fainting during treatment. Most people find it relatively safe with minimal discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have experienced significant pain, fatigue, or sleep problems in the last three months.
Select...
I finished my main cancer treatment between 3 months and 5 years ago.
Select...
I have been diagnosed with early to mid-stage breast cancer.
Select...
I am currently on hormone therapy for cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after 10th acupuncture treatment, at 6 weeks post-baseline (study completion)
This trial's timeline: 3 weeks for screening, Varies for treatment, and after 10th acupuncture treatment, at 6 weeks post-baseline (study completion) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
PROMIS Fatigue
PROMIS Pain Interference
PROMIS Sleep Disturbance
Secondary outcome measures
PROMIS Anxiety
PROMIS Depression

Side effects data

From 2013 Phase 1 & 2 trial • 104 Patients • NCT01305811
2%
Serious unexpected
2%
Pain on needling
100%
80%
60%
40%
20%
0%
Study treatment Arm
Bi-Weekly Acupuncture
Wait List

Trial Design

1Treatment groups
Experimental Treatment
Group I: AcupunctureExperimental Treatment1 Intervention
All subjects will receive active acupuncture. The acupuncture intervention will consist of 10 acupuncture sessions, twice weekly for 5 weeks. There will be at least 1 day in between session.

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
604 Previous Clinical Trials
1,558,929 Total Patients Enrolled
10 Trials studying Breast Cancer
1,342,290 Patients Enrolled for Breast Cancer

Media Library

Acupuncture Clinical Trial Eligibility Overview. Trial Name: NCT05417451 — N/A
Breast Cancer Research Study Groups: Acupuncture
Breast Cancer Clinical Trial 2023: Acupuncture Highlights & Side Effects. Trial Name: NCT05417451 — N/A
Acupuncture 2023 Treatment Timeline for Medical Study. Trial Name: NCT05417451 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for volunteers to partake in the current experiment?

"According to the data on clinicaltrials.gov, this medical study is not currently open for recruitment. Initially posted in November 2021 and last updated September 2022, it appears that there are no patients being sought at this time; however, 2603 other trials remain active with enrollment openings."

Answered by AI
~22 spots leftby May 2025